Form 4: Danaher Executive Weidemanis Receives Stock Options and Restricted Stock Units

Executive Vice President Joakim Weidemanis of Danaher Corp. was granted stock options and restricted stock units on March 1, 2024, according to a Form 4 filing.

Summary

• Joakim Weidemanis, an Executive Vice President at Danaher Corp, received stock options and restricted stock units (RSUs) on March 1, 2024.
• He acquired 978 shares of common stock through restricted stock units.
• He was granted 25,590 employee stock options with an exercise price of $255.87, exercisable in two tranches on the third and fourth anniversaries of the grant date.
• He also received 2,327 employee stock options with an exercise price of $255.87, exercisable in four tranches on the first four anniversaries of the grant date.
• Following the reported transactions, Weidemanis beneficially owns 90,412 shares of Danaher common stock.
• He also owns 25,590 and 2,327 derivative securities.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing related to executive compensation. It doesn't contain information that would significantly sway investor sentiment positively or negatively. The sentiment is neutral to slightly positive due to the alignment of executive and shareholder interests.

Positives

• The grant of stock options and RSUs to a key executive like Weidemanis aligns his interests with those of the shareholders, incentivizing him to drive company performance.
• The vesting schedules of the options and RSUs (over 3-4 years) encourage long-term commitment from the executive.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Stock option and RSU grants are a common practice in executive compensation packages within publicly traded companies like Danaher to incentivize performance and align executive interests with shareholder value.

Comparison to Industry Standards

• Danaher's executive compensation practices, including the use of stock options and RSUs, are generally in line with industry standards for large, publicly traded corporations.
• Companies like Thermo Fisher Scientific, Abbott Laboratories, and Siemens Healthineers also utilize similar equity-based compensation strategies to attract and retain top talent.
• The specific terms of the grants, such as vesting schedules and exercise prices, would need to be compared against peer companies to determine if they are above, below, or in line with the market.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign, aligning executive interests with company performance.
• Employees may see the grants as a reflection of the company's commitment to its leadership team.

Key Dates